|
AGFG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.155900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.557200E-01 |
| Normal-vs-Stage2 |
2.210200E-01 |
| Normal-vs-Stage3 |
4.454300E-02 |
| Normal-vs-Stage4 |
2.260400E-01 |
| Stage1-vs-Stage2 |
2.996400E-01 |
| Stage1-vs-Stage3 |
9.772000E-02 |
| Stage1-vs-Stage4 |
3.228600E-01 |
| Stage2-vs-Stage3 |
5.534200E-01 |
| Stage2-vs-Stage4 |
6.667600E-01 |
| Stage3-vs-Stage4 |
9.660800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.458180E-01 |
| Normal-vs-AfricanAmerican |
1.315610E-01 |
| Normal-vs-Asian |
4.205000E-01 |
| Caucasian-vs-AfricanAmerican |
5.575200E-01 |
| Caucasian-vs-Asian |
4.823400E-01 |
| AfricanAmerican-vs-Asian |
6.619800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.182200E-01 |
| Normal-vs-Female |
2.101800E-03 |
| Male-vs-Female |
9.278000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.866400E-01 |
| Normal-vs-Extreme_Weight |
9.336600E-01 |
| Normal-vs-Obese |
1.982060E-02 |
| Normal-vs-Extreme_Obese |
6.788600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.337400E-01 |
| Normal_Weight-vs-Obese |
1.191410E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.841200E-01 |
| Extreme_Weight-vs-Obese |
1.879850E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.886800E-01 |
| Obese-vs-Extreme_Obese |
4.840800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.393930E-02 |
| Normal-vs-Age(41-60Yrs) |
1.524040E-02 |
| Normal-vs-Age(61-80Yrs) |
6.576400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.444800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.168100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.802270E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.128470E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.037900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.095360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.515400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.241770E-01 |
| Normal-VS-Type2 PRCC |
9.049000E-01 |
| Normal-VS-KIRP CIMP |
2.840000E-03 |
| Normal-VS-Unclassified PRCC |
6.889600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.431000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.462200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.926200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.115700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
8.474000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.060000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.304000E-01 |
| Normal-vs-N1 |
5.536100E-03 |
| Normal-vs-N2 |
3.195900E-02 |
| N0-vs-N1 |
4.619900E-03 |
| N0-vs-N2 |
1.712040E-01 |
| N1-vs-N2 |
5.460600E-01 |
|
|
